Fludrocortisone acetate
SIGMA/F6127 - ≥98%
Synonym: 9α-Fluoro-11β,17α,21-trihydroxy-4-pregnene-3,20-dione acetate; 9-Fluorocortisol acetate; 9-
CAS Number: 514-36-3
Empirical Formula (Hill Notation): C23H31FO6
Molecular Weight: 422.49
EC Number: 208-180-4
MDL Number: MFCD00864160
Linear Formula: C23H31FO6
Product Type: Chemical
| assay | ≥98% |
| biological source | synthetic |
| form | powder |
| InChI | 1S/C23H31FO6/c1-13(25)30- |
| InChI key | SYWHXTATXSMDSB-GSLJADNHSA |
| Quality Level | 100 ![]() |
| shipped in | ambient |
| SMILES string | CC(=O)OCC(=O)[C@@]1(O)CC[ |
| solubility | acetone: 50 mg/mL, clear, colorless to light yellow |
| sterility | non-sterile |
| storage temp. | room temp |
| Biochem/physiol Actions: | Fludrocortisone acetate is a synthetic corticosteroid with more mineralocorticoid than glucocorticoid activity. |
| General description: | Fludrocortisone acetate is secreted by adrenal cortex. It increases the reabsorption of sodium and secretion of potassium and hydrogen. Fludrocortisone is used to treat cerebral salt wasting syndrome and adrenal insufficiency. Fludrocortisone improves the sensitivity of blood vessels to catecholamines and increases the blood volume. |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H302 - H361 |
| Precautionary statements | P201 - P301 + P312 + P330 - P308 + P313 |
| Hazard Codes | Xn |
| Risk Statements | 63 |
| Safety Statements | 22-26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |



